ULCERATIVE COLITIS (UC)
Clinical trials for ULCERATIVE COLITIS (UC) explained in plain language.
Never miss a new study
Get alerted when new ULCERATIVE COLITIS (UC) trials appear
Sign up with your email to follow new studies for ULCERATIVE COLITIS (UC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for ulcerative colitis sufferers
Disease control CompletedThis study tested a new drug called IBI112 in 150 people with moderate to severe ulcerative colitis, a condition that causes inflammation and sores in the colon. The goal was to see if IBI112 could help patients reach clinical remission (no symptoms) after 12 weeks of treatment. …
Matched conditions: ULCERATIVE COLITIS (UC)
Phase: PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New drug VedAryo® shows promise for IBD patients in Real-World study
Disease control CompletedThis study followed 150 people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who were treated with VedAryo® (vedolizumab). The goal was to see if the drug helps control symptoms and is safe over 52 weeks. Researchers measured improvements in disease acti…
Matched conditions: ULCERATIVE COLITIS (UC)
Sponsor: AryoGen Pharmed Co. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC